| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |